Efficacy of the silicon based agent for age related decline in vestibular function
- PMID: 40813876
- PMCID: PMC12354867
- DOI: 10.1038/s41598-025-14302-7
Efficacy of the silicon based agent for age related decline in vestibular function
Abstract
Age-related vertigo and balance disorders can lead to falls, fractures, and prolonged confinement to bed. Loss of mobility and/or social interaction may cause cognitive decline and lower quality of life, resulting in significant social and economic burdens. Aging societies urgently need treatments for vestibular decline, as no cures exist, and current therapies only provide symptomatic relief. Oxidative stress contributes to age-related cochlear balance system damage, making antioxidants a potential treatment. Silicon-based agent (Si-agent) is an excellent antioxidant. When reacting with water, this agent produces hydrogen continuously, offering sustained antioxidant effects. Oral Si-agent has alleviated oxidative stress-related diseases in mouse models, such as ulcerative colitis and Parkinson's disease. This study evaluated Si-agent for age-related vestibular decline in mice. In balance beam tests, Si-agents-treated group showed less balance decline with age compared to untreated mice. However, vestibulo-ocular reflex (VOR) tests measuring semicircular canal and otolith organ function showed no significant differences. In linear VOR, no significant differences were observed at any frequency; however, a significant difference was found in the average slope of linear decline between 0.7 and 0.9 G. Structural damage to the inner ear's semicircular canals and otolith organs was also reduced in Si-agents-treated group. These findings suggest that Si- agent may help treat age-related in balance and motor decline.
Keywords: Aging; Decline in vestibular function; Oxidative stress; Si-based agent; Vestibulo-ocular reflex.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethical approval: All animal experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The experimental protocols were approved by the Committee of Animal Experiments of Osaka University (approval number 01-072-014). Our study was completed in compliance with the ARRIVE guidelines for the mouse experiments and the American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals. Every effort was made to minimize the number of mice and reduce their suffering. When the mice had difficulty consuming food and water, food was placed on the bedding, and agar jelly was provided as a supplement. Additionally, if any abnormalities or potential humane endpoints (such as difficulty eating/drinking, breathing issues, self-injury, or a rapid weight loss of ≥ 20% within a few days) were observed, the mice were promptly euthanized through intraperitoneal injection of pentobarbital (200 mg/kg).
Figures






References
-
- Neuhauser, H. K. Epidemiology of vertigo. Curr. Opin. Neurol.20, 40–46. 10.1097/WCO.0b013e328013f432 (2007). - PubMed
-
- Walther, L. E. & Westhofen, M. Presbyvertigo-aging of otoconia and vestibular sensory cells. J. Vestib. Res.17, 89–92 (2007). - PubMed
-
- Brosel, S., Laub, C., Averdam, A., Bender, A. & Elstner, M. Molecular aging of the mammalian vestibular system. Age. Res. Rev.26, 72–80. 10.1016/j.arr.2015.12.007 (2016). - PubMed
-
- Kikkawa, Y. S., Nakagawa, T., Taniguchi, M. & Ito, J. Hydrogen protects auditory hair cells from cisplatin-induced free radicals. Neurosci. Lett.579, 125–129. 10.1016/j.neulet.2014.07.025 (2014). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources